Southside Cancer Care Centre

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Bladder cancer1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Kidney cancer1 trial
• Melanoma1 trial
• Prostate cancer1 trial

Phase

• Phase 1/22 trials
• Phase 31 trial

Status

• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Aulos Bioscience, Inc.1 trial
• BrYet US, Inc.1 trial
• pharmaand GmbH1 trial

Running trials

• Recruiting

  ML-016 in Advanced Cancer With Lung and/or Liver Involvement

  NCT07723482· Phase 1/2· BrYet US, Inc.· Source

  Contact: Kareena Young

• Recruiting

  Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

  NCT05267626· Phase 1/2· Aulos Bioscience, Inc.· Source

  Contact: Paul DeSouza

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting
• Bladder cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• Kidney cancer1 recruiting
• Melanoma1 recruiting

Closed trials

• Completed

  A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

  NCT02975934· Phase 3· pharmaand GmbH· Source